Position
Fidelity in Cogent Biosciences, Inc.
Back to the book · All holders of COGT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $8.87M$36.23 → $36.59
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 24.6M | $821.8M | — | — | — | 0.0% |
| Q1 2026 | 24.6M | $891.8M | $36.23 | $68.7M | $1.3M | 0.0% |
| Q2 2026 | 27.2M | $995.8M | $36.59 | $8.87M | $95.1M | 0.0% |